Balchem (BCPC) Stock Price, News & Analysis

Company Overview

Balchem Corporation is a specialty ingredients and products company that develops, manufactures and markets nutritional, health and performance products for customers in the food, nutrition, animal health and industrial markets. The company uses technologies including microencapsulation, chelation and other formulation processes to improve the stability, delivery and functionality of ingredients.

Balchem’s Human Nutrition and Health business supplies minerals, vitamins, choline, methylfolate and other specialty nutrients used in dietary supplements, functional foods, beverages and pharmaceutical applications. Its Animal Nutrition and Health business provides nutritional ingredients, trace minerals, encapsulated products and other solutions designed to support animal health, feed efficiency and livestock production.

The company’s Specialty Products business serves industrial and commercial customers with products used in areas such as water treatment, food processing, personal care and other specialized applications. Balchem was founded in 1967 and is headquartered in New Hampton, New York. It serves customers in the United States and international markets, and is led by President and Chief Executive Officer Ted W. Harris Jr.

Key Stats

• Today's Range: $170.25 to $172.74
• 50-Day Range: $163.69 to $181.28
• 52-Week Range: $147.18 to $183.90
• Volume: 452,858 shs
• Average Volume: 246,579 shs
• Market Capitalization: $5.44 billion
• P/E Ratio: 33.55
• Dividend Yield: 0.56%
• Price Target: $197.33
• Consensus Rating: Buy

Balchem Stock Analysis - MarketRank™

Balchem scored higher than 73% of companies evaluated by MarketBeat, and ranked 105th out of 228 stocks in the materials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.3 / 5
• Analyst Rating: Buy

Consensus Rating

Balchem has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 strong buy rating, 3 buy ratings, 1 hold rating, and no sell ratings.

Upside Potential

Balchem has a consensus price target of $197.33, representing about 15.5% upside from its current price of $170.78.

Amount of Analyst Coverage

Balchem has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 5.49%

Earnings Growth

Earnings for Balchem are expected to grow by 5.49% in the coming year, from $5.83 to $6.15 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Balchem is 33.55, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 36.44.

Price to Earnings Ratio vs. Sector

The P/E ratio of Balchem is 33.55, which means that it is trading at a more expensive P/E ratio than the Materials sector average P/E ratio of about 22.14.

Price to Earnings Growth Ratio

Balchem has a PEG Ratio of 3.10. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Balchem has a P/B Ratio of 4.40. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.57% of the float of Balchem has been sold short.

Short Interest Ratio / Days to Cover

Balchem has a short interest ratio ("days to cover") of 2.08, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Balchem has recently decreased by 20.49%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 3.3 / 5
• Dividend Strength: Strong

Dividend Yield

Balchem has a dividend yield of 0.56%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Balchem has been increasing its dividend for 16 years.

Dividend Coverage

The dividend payout ratio of Balchem is 18.86%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Balchem will have a dividend payout ratio of 15.61% next year. This indicates that Balchem will be able to sustain or increase its dividend.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Sentiment

Balchem has a news sentiment score of -2.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.42 average news sentiment score of Materials companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Balchem this week, compared to 3 articles on an average week.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Balchem insiders have not sold or bought any company stock.

Percentage Held by Insiders

1.65% of the stock of Balchem is held by insiders.

Percentage Held by Institutions

87.91% of the stock of Balchem is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 7/31/2026
• Today: 10/22/2026
• Next Earnings (Estimated): 10/23/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Materials
• Industry: Chemicals
• Sub-Industry: Specialty Chemicals
• Current Symbol: NASDAQ:BCPC
• Previous Symbol: NASDAQ:BCPC
• CIK: 9326
• Web: www.balchem.com
• Phone: (845) 326-5600
• Fax: 845-326-5717
• Employees: 1,352
• Year Founded: 1967

Price Target and Rating

• Average Price Target for Balchem: $197.33
• High Price Target: $215.00
• Low Price Target: $162.00
• Potential Upside/Downside: +15.5%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 5 Analysts

Profitability

• EPS (Trailing Twelve Months): $5.09
• Trailing P/E Ratio: 33.55
• Forward P/E Ratio: 29.29
• P/E Growth: 3.1
• Net Income: $154.85 million
• Net Margins: 15.14%
• Pretax Margin: 19.56%
• Return on Equity: 13.80%
• Return on Assets: 10.55%

Debt

• Debt-to-Equity Ratio: 0.14
• Current Ratio: 2.66
• Quick Ratio: 1.56

Sales & Book Value

• Annual Sales: $1.04 billion
• Price / Sales: 5.25
• Cash Flow: $6.56 per share
• Price / Cash Flow: 26.02
• Book Value: $38.83 per share
• Price / Book: 4.40

Miscellaneous

• Outstanding Shares: 31,880,000
• Free Float: 31,352,000
• Market Cap: $5.44 billion
• Optionable: Optionable
• Beta: 0.85